Audrey’s Selected Meeting List for January 2008



Audrey’s Life Science Meeting Picks for Nov., 2009

(Nov. 21st Edition)

***************************************************************

TAITA, Tuesday Evening, Nov. 24, 2009

Topic: "How to buildup a medical device startup efficiently"

Speaker: Roy Chin

Date and Time: Nov. 24, 2009 (Tue.), 6:30 - 9:00 pm,

Location:: ITRI International, Rm. 140, 2870 Zanker Road, SJ, CA

Registration: Student:Free, $5 member, $10 non-member, (light snack provided)

RSVP: Kevin Ho kevin@.tw

Topic Description

In order to take a medical device startup from concept to commercialization to exit, it requires flawless execution, such as great intellectual property positioning in both freedom to operate and patentability, procedural development, product development, favorable regulatory strategy, selection of passionate and committed management team and selection of key opinion leaders in physicians, and education of physicians through the effective sales and marketing channels.

The talk will also include the importance of appropriate financing and the involvement of corporates and bankers that lead to the eventual exit.

Speaker Bio

Mr. Chin brings over 21 years of experience in medical device industry pioneering advanced technologies and new surgical procedures and turning conceptual ideas into commercialized products. He is currently the CEO of SpineView, a company focusing on revolutionary spinal technologies for decompression and fusion. Mr. Chin has taken SpineView from inception in 2006 to FDA clearance in August 2008, and product commercialization in 2009, while raising more than $15MM in financing. Prior to starting SpineView, Mr. Chin spent 4 years with AFx, where he developed all the minimally invasive devices to treat

atrial fibrillation and worked with more than 100 physicians in endoscopic procedures prior to AFx acquisition by Guidant in 2004. Prior to AFx, Mr. Chin was with CardioThoracic Systems (CTS), a company developing stabilizer and endoscopic vein harvesting systems for minimally invasive beating heart coronary bypass surgery. CTS was acquired by Guidant in 1999. Prior to that he was with Stryker Endoscopy since 1988 in various managerial and engineering capacities developing technologies for knee and shoulder arthroscopy, ENT, and general surgery. Currently, Mr. Chin is also the founder and a member of the Board of Directors for NanoNerve and NanoVasc. Mr. Chin is the patent holder to several patents and more than 50 pending patents. Roy holds a Bachelor of Science degree in Electrical Engineering from University of Kansas.

****************************************************

Bio2Device Group, Tuesday Morning, Dec. 1, 2009

Topic: “From Bench to Bedside”: Collaboration of Industry and Non-Profit Research in Developing New Therapies and Diagnostics’

Speaker: Ian Irwin, Director, Translational Drug Development, The Parkinson’s Institute and Clinical Center

Date and Time: Tuesday, Dec. 1, 2009, 8:30 – 10:30 am

Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library)

Cost: Free

Parking: On street and in NOVA and library parking lots across the street.

Topic Description

The Parkinson’s Institute, located in Sunnyvale, CA was founded in 1988, by Dr. J. William Langston, The Parkinson’s Institute and Clinical Center is an internationally recognized, independent non-profit foundation.  We perform basic and clinical research, clinical trials and operate a comprehensive movement disorder patient clinic for the treatment of Parkinson’s disease and related disorders, all under one roof. Our mission is to find the causes, provide first class patient care and develop new diagnostic tools and treatments for this disorder. Our unique freestanding organization supports a strong collaboration of translational medicine component, designed to more directly connect research to patient care – from the "lab bench to bedside".   Our web site at  expands further on our achievements and capacities. The Institute has a history of working closely with Industry and we are very committed to the development of new therapies and tools for early diagnosis of the disease. 

Speaker Bio

Ian Irwin is a scientist with over 25 years of experience in Parkinson’s research, drug discovery and development. As head of the Drug Assay Lab at Stanford University (1978-1983), he was the chemist on the team who identified MPTP as the agent responsible for the outbreak of Parkinsonism in heroin addicts in 1982. Director of Neurochemistry at the Parkinson’s Institute (1984-1998), his research with MPTP was key to establishing the MPTP-model of Parkinson’s disease and understanding the mechanism of action of this toxin. Research leader at Centaur Pharmaceuticals (1999-2003) and Senior Director of drug metabolism at ARYx therapeutics (2003-2008), he has worked in the pharmaceutical industry on discovery, pre-clinical and clinical development programs for Parkinson’s disease and other disorders, with 5 drugs moving from discovery through phase 2 clinical trials. He is currently the Director of Translational Drug Development at the Parkinson’s Institute. His research focuses discovery and development new treatments for Parkinson’s disease.

**********************************************************

Bioscience Business Development: Building Value, Thursday and Friday, Dec. 3-4, 2009

Intensive Course: Bioscience Business Development: Building Value, Thursday and Friday, Dec. 3-4, 2009 ((2 days of classroom and 2 months to complete project guided by instructor)

Instructors: Audrey S. Erbes, Ph.D., Principal, Erbes & Associates and and and Gilbert R. Mintz, Ph.D., President of GRM Associates

Expert Guest Speakers:

▪ Harold (Hal) Etterman, MBA, Business Strategist

▪ Carolyn Feamster, MBA, VP, Business Strategy & Analysis

▪ Jim Fox, Ph.D, J.D., Goodwin Procter LLP

▪ Tom Gutshall, Chairman & Co-Founder of Cepheid

▪ Michael G. McCully, M.S., Director, Recombinant Capital

Please see ucsc-extension.edu/biobizdev for complete biographies

Date & Time: Oct. 8-9, 2009, Thursday and Friday, 8:30am-5pm

Location: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa Clara, CA 95053

Fee: $770

Topic Description

UCSC Extension in Silicon Valley presents a two-day intensive course that brings the breadth of the Bay Area’s biobusiness development expertise to our Cupertino classroom. Whether financing start-up activities, trying to keep pace with the current burn rate, or moving a product into the marketplace, bioscience companies, both large and small, have a critical need for business development at every stage of their evolution. Learn the key roles that business development and licensing play in the commercialization of a new product and the development of a successful bioscience company. Santa Clara, CA. For more information, see ucsc-extension.edu/biobizdev

Instructor Bios

Audrey Erbes, Ph.D., Principal, Erbes & Associates and has more than 35 years of marketing experience in the biotech and pharmaceutical industries, of which 25 years was in corporate management at Kowa Research Institute and Syntex Corporation.

Gilbert R. Mintz, Ph.D., President of GRM Associates, a biotechnology consulting firm with expertise in business development, licensing and strategic planning.

**********************************************************

San Jose Biocenter, Thursday Late Afternoon, Dec. 3rd, 2009

Topic: Trends in Financing Investor Panel & Holiday Celebration

Speakers include:

• Janis Naeve, PhD, Director, Amgen Ventures Click Here for Bio»

• Doug Fisher, Principal, InterWest Partners LLC Click Here for Bio»

• Samuel Wu, MD, PhD, Principal, SV Life Sciences Click Here for Bio» or Sarah Bodary, PhD, Venture Partner, SV Life Sciences Click Here for Bio»

• Jim Long, Partner, Gabriel Venture Partners Click Here for Bio»

• Lead Facilitator: Stephen Venuto, Partner, Orrick, Herrington & Sutcliffe LLP Click Here for Bio»

Date and Time: Thursday December 3, 2009 | 3pm-6:30pm

Location: Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Building 1100, Menlo Park, CA 94025-1015

Click here for Venue Directions»

This event is typically sold out, so pre-registration is recommended to avoid disappointment on the day!

• Regular Price: $60

• Partners' Network: $50

• BioCenter Members: Free (please RSVP to Aurélie)

• On-site Registration: add $10 to the above

See registration at

Topic Description

Steady capital is a must for all companies.  The first step in funding is knowing where to look.  Join experts from the investment world to understand the types of financing that are occurring in your industry today, and what can be expected for 2010.

Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Holiday Celebration Networking Reception.

****************************************************

Pharmaceutical Executive Webcast, Thursday Morning , Dec. 3, 2009

Topic: “Building Market Share Through Patient Segmentation Strategies: New Ideas and Best Practices to Enhance ROI”

Moderator: William Looney ,Editor in Chief ,Pharmaceutical Executive

Presenter: Andrea Pearson , Senior Vice President Internet Strategy and Operations ,Healthgrades

Date and Time: Thursday Morning, Dec. 3rd, 8:30 am PT (11:30am EST)

Cost: Free

Register at marketshare

Event Overview

Pharmaceutical and medical device marketers confront growing pressure to demonstrate return on investment [ROI] in consumer advertising and brand awareness. Real metrics of performance against budgeted ad dollars are critical, especially as available resources shrink.

Budgets for marketing are down by an average 10 percent this year and the evidence shows that pharmaceutical companies continue to spend 65 percent of that on DTC ads for television – despite the fact that only a small percentage of viewers stand out as potential customers for their medicines. The ability to target scarce resources to build access to the customers most likely to yield the best return on prescriptions written is thus more vital than ever.

In this webcast, you’ll learn how consumer segmentation analysis can improve return on investment and lead to the application of interactive media strategies in a way that is more engaging and effective than reliance on television, magazines and other traditional mass media.

In the webcast you will learn:

• New ways that pharmaceutical and medical device companies can segment consumer markets to improve marketing effectiveness and best leverage limited advertising dollars. To identify one or more new consumer segments that are better targets for your brand.

• How to tap interactive media channels to engage directly with patients.

• How to educate physicians about your brand via their patients.

Who Should Attend:

• Market Asset Team Leaders

• Product Manager (including director and VP level)

• Brand Manager (including director and VP level)

• VP of Marketing

• CMO (Chief Marketing Officer)

• Media and Communications

****************************************************

Northern California Analytical Chemists, Friday Lunch, Dec. 4, 2009

Event Name: Use of Nano Particle Technology to Enhance Performance of Pharmaceutical Products

Speakers: Niels Ryde, Ph.D., Elan Drug Technologies

Date and Time: Friday, December 04, 2009, 11:00-1330

Location: Foster City Crowne Plaza

Event fee:$0 online before closing; $40 on site.

Online registration and further details:

Registration deadline: 12/2/2009  (it will close sooner if the seating cap is reached)

Additional Details: Visit the luncheons page Visit CACO website

****************************************************

UCSC Extension in Silicon Valley, Saturday Dec. 5, 2009

Course: Biotechnology Basics for Non-Scientists

Date and Time: Saturday, Dec. 5, 2009, 9:00 am – 4:00 pm

Location: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa Clara

Tuition: $235; Early enrollment discount $211.50

Course Description

Biotechnology focused articles appear in the newspapers almost every day. For the layperson, it can be a challenge to understand and appreciate this technology and its potential implications for human health, public policy and the Bay Area economy. This seminar provides non-scientists with an accessible and stimulating introduction to the world of biotechnology. The course begins with an overview of the basic concepts in molecular biology and genetics that serve as a foundation for biotechnology. The instructor then highlights gene-based technology and important biotechnology breakthroughs, especially as they relate to Bay Area companies and institutions. He explores the impacts and the future of this cutting-edge discipline, and students leave the course with a new vocabulary and a solid understanding of the power and potential of biotechnology. No scientific background is assumed.

Instructor Background

Raxit J. Jariwalla, Ph.D., is senior researcher in nutrition and infectious diseases at the Dr. Rath Research Institute in Santa Clara, California. He was formerly head of the virology and immunodeficiency research program at the Linus Pauling Institute of Science and Medicine, and principal research investigator at the California Institute for Medical Research. Dr. Jariwalla is recognized for his contributions to virology, carcinogenesis, immunodeficiency disease and nutrition research.

Bottom of Form

***************************************************************Palo Alto AWIS, Monday Evening, Dec 7, 2009

Event: “Winter Networking Social

Date and Time: Monday, Dec. 7, 2009, Time: 7 - 9 pm

7:00-7:30 pm Light supper

7:30-9:00 pm Networking activities

Place: PARC Auditorium, 3333 Coyote Hill Road, Palo Alto, CA

Cost: Members pay $5 and non-members pay $10 to offset the cost of food.

Event Description

WHO AWIS Members & Friends • Scientists • Engineers • Educators • Students

Researchers • Writers • Business Representatives • Men too!

WHAT A reception with great food, fun games, and active networking activities

WHY Meet new people. Expand your social and professional networks.

Have fun!

RSVP Online

Welcome!! You don’t need to be a member to attend. All scientists, students, and their friends are

welcome.

************************************************************

Bay Bio Medical Device Breakfast, Tuesday Morning, Dec. 8, 2009

Topic: “Company Valuation for M&A”

Moderator: Mark Weeks, Partner, Cooley Godward Kronish LLP

Panel Speakers:

Jason Yip, Principal, Montgomery & Co., LLC

Jeffrey Gold, Venture Partner, Longitude Capital, Former CEO, CryoVascular Systems

Time and Date: Dec. 8, 2009, 8:00 -10:00 am

Location: Cooley Godward Kronish LLP, Palo Alto Campus, 3175 Hanover Street, Palo Alto, CA 94304

Early Bird Registration through Dec. 4:

$10.00 - BayBio & MDMA Members, Bio2Device and Bio-X Affiliates

$20.00 - Non-Members

On-Site Registration, Dec. 8:

$20.00 - BayBio & MDMA Members, Bio2Device and Bio-X Affiliates

$40.00 - Non-Members

Register at

Topic Description

The valuation of a medical device company for merger or acquisition is not an exact science. Some of the many variables to be taken into consideration include the company’s management, market share, prospects for growth, and potential market size. Tangible and intangible assets and financial track record will be evaluated, as well as the company's reputation in the business community. The motivation and goals of key players also come into play, and current market conditions and timing are factors. A panel of industry veterans will explore the valuation process for medical device companies, discuss case studies and provide practical answers to help you increase your company’s valuation.

*******************************************************************************************************************************

Bio2Device Group, Tuesday Evening, Dec. 8, 2009

Topic: “Science + Commercialization = Valuation. Building a Commercial Story that Resonates with Prospective Partners.”

Speaker: Harris Kaplan, President and Chief Executive Officer, Healogix

Date and Time: Tuesday, Dec.. 8, 2009, 6:00 – 9:00 pm

Location: Location: TIPS Group Law Offices , 1000 Elwell Court, Palo Alto, CA 94303

Advanced registration is required see website for details a week prior to event.

Cost: Fee for light dinner with range depending on timing of registration:

Topic Description

The biotech IPO window has been closed for some time now and is unlikely to reopen anytime soon. As a result, biotech executives are increasingly reliant on a big pharma or big biotech to provide the capital needed to continue to develop promising new compounds and the competition for pharma or biotech dollars is intense. The larger companies differ significantly from financial investors. They are at least as concerned about how the product will perform in the market post launch as they are about the science. Thus, it is as important for a biotech executive understand the commercialization opportunity and to make that story come to life for an executive. Think venture capital but without a requirement that “monies have to be put to work.”  A biotech executive has to make one of these larger companies want to do a deal with your company.

This talk will focus on how biotech executives go about building a robust commercial story – what elements need to be included in that story and how to position compounds so they are very attractive to pharma and big biotech scientists and business development executives. Most biotech deals get one opportunity to present their technology and/or product. This talk will help company executives make that one time count.

Speaker Bio

Harris Kaplan is currently President and Chief Executive Officer of Healogix, a consultancy formed in late 2005 that advises companies on how to create and maximize the value of new products in development.

Harris has extensive experience in the pharmaceutical industry both on the client and consulting side of the business and has worked on the introduction of more than 75 new products including Lipitor, Crestor, Nexium, Rituxan, and Herceptin.

Harris co-founded Migliara-Kaplan Associates which became the world’s largest custom marketing research company serving 19 of the top 20 pharmaceutical companies. Migliara-Kaplan Associates specialized in helping companies identify new product opportunities and then maximizing the commercial potential of new products in development. Migliara-Kaplan was acquired by NFO in 1996 and is now part of TNS Healthcare. Harris was also cofounder of Cozint Interactive which was acquired by GFK, the German based research company. Harris serves as an advisor to several venture capital funds and is on the Board of Directors of Informedix and the Kernan Orthopedic Hospital.

************************************************************

Tri-Valley IMC Consultants Forum Breakfast, Wednesday Morning, Dec. 9, 2009

Topic: "Planning for a Successful 2010" presented by a panel of our own members.

Date and Time: December 9, 7:15 - 9:00 a.m.

Location: San Ramon Marriott Hotel

Cost: $20 in advance ($25 at the door) includes breakfast.

Register at

Who Should Attend?

• Consultants eager to enhance their practices with new tools and professional development

• Experienced professionals planning to launch a second career in consulting

• Independent management consultants looking to collaborate with other like minded professionals

• Business advisors wondering if certification as a management consultant (CMC©) would add credibility to their practices

If you fit ANY of the above, you owe it to yourself to attend this meeting. Space is Limited.



For more information about Tri-Valley Consult ants Forum or the December meeting, go to the Tri-Valley Consultants Forum Linked-In Group site at

or e-mail TriValleyIMCConsultantsForum@

This group/forum is for professional consultants based in the 580/680 corridor, from Martinez to Hayward, Livermore to Castro Valley. The objective is to create an atmosphere of partnership, comraderie and the exchange of best practices. The group will conduct monthly meetings with presenters speaking to topics for consultants starting in September '09 in the San Ramon, CA area.

*************************************

GABA, Tuesday Lunchtime, Dec. 15, 2009

Topic: “New Solutions for the Medical Arena - The Fraunhofer Heinrich Hertz Institute and Its Latest Developments”

Speakers:

❖ Prof. Hans-Joachim Grallert, Managing Director Heinrich Hertz Institute

❖ Ulrich Leiner, Dept. Head Interactive Media, Heinrich Hertz Institute

❖ Juergen Rurainsky, Dept. Image Processing, Heinrich Hertz Institute

Date and Time: Tuesday, Dec 15, 2009, 11:30 AM - 02:00 PM

11:30 - 12:00 pm Registration / Networking Reception

12:00 - 12:20 pm Welcome and Intro Heinrich Hertz Institute

12:20 - 12:50 pm 3-D in Theory und Practise, Touchless Applications for Medical Purposes

12:50 - 01:20 pm Image Processing and its Contributions for the Medical Arena

01:20 - 01:30 pm Discussion of the requirements and needs from the medical perspective

followed by a Guided Tour of the 2-D-Displays, Gesture Interface and

Complimentary lunch included.

Location: Mission Bay Conference Center at UCSF, 1675 Owens Street, San Francisco, CA

Early registration is recommended since space is limited. This event is free of charge with online registration. Register at

Topic Description

The cost of healthcare can be reduced through the use of more efficient medical visualization, image processing and diagnostic tools. The Fraunhofer Heinrich Hertz Institute, a leading international applied research institute, has made groundbreaking developments in these areas.

Come and join us for an insight into these exciting and efficient technologies and a Q&A session following the presentation.

New Displays and Interfaces: Using the virtual reality of 3-D co-operation spaces allows for better orientation and teamwork, and a faster analysis or response to a given situation. The speakers will show different 3-D approaches in theory and practice and demonstrate touchless control and applications for medical purposes.

Image Processing and Diagnostics: To analyze and categorize the huge amount of data provided by the new imaging technologies is a great challenge. Fraunhofer developed solutions for creating, archiving and processing great amounts of visual data such as images derived from electronic endoscopy, wireless sensor networks, auto-stereoscopic 3-D displays, picture and video retrieval systems, as well as new ways to find and compare similar disease patterns.

See the following exhibits:

• New 3-D Displays: Experience 3-D without wearing glasses

• iPointPresenter: Touchless gesture controll 

Connecting the different areas of competence creates a great variety of novel approaches and solutions with significant economic transfer potential. To mention a few:

• autostereoscopic 3D displays for medical applications such as diagnosis and education

• touchless interaction of devices and systems in a sterile environment; the optimisation of the workflow during surgery under sterile conditions requires the application of new interactive technologies

• electronic endoscopy; with the help of intelligent coding procedures, the signal processing of the HD signal at source can be carried out in an energy-efficient manner and free of loss

• sensor networks via air (e.g. generating/transmitting vital-data)

• video-retrival and –analysis for finding and comparing similar disease patterns to support diagnosis verification

**********************************************************

Bio2Device Group, Tuesday Morning, Dec. 15, 2009

Event: Special Holiday Networking Event

Date and Time: Tuesday, Dec. 15, 8:30 am

Location: TIPS Facility (our normal Evening Meeting Facility), 1000 Newell Rd., Palo Alto

There is no meeting at the Sunnyvale City Chambers for this last meeting of 2009.

Please preregister for the event.  There will be no charge for the event, but please log into the

Google Checkout and register for the morning Holiday Networking event.

Your registering will allow B2DG to know ahead of time how many members and

guests to expect (need to know how much food to buy- can't fully celebrate

without food and drink). There will be a limit of total attendees of 85.

********************************************************

BioScience Forum, Wednesday Evening, Dec. 16, 2009

Topic: TBA

Speaker: Jake Plattner, Ph.D., Senior Vice President, Research, Anacor

Date and Time: Wednesday, Dec. 16, 2009

Time: 6pm Networking, 7pm Dinner, 8pm Presentation

Location: Location: The Clarion Hotel, 401 East Millbrae Ave., Millbrae, CA

Registration is $50 ($35 for full-time students). Parking $4. On-site registration: add $10 to pre-registered price. Register online at before Monday, Dec. 14, 2009 at 11:55pm.

See further details later this month.

****************************************************************************************[pic][pic][pic]

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download